Galiñanes M, Ferrari R, Qiu Y, Cargnoni A, Ezrin A, Hearse D J
Cardiovascular Research, Rayne Institute, St Thomas' Hospital, London, UK.
J Mol Cell Cardiol. 1992 Sep;24(9):1021-30. doi: 10.1016/0022-2828(92)91868-6.
We have previously shown that the polyethylene glycol conjugated superoxide dismutase (SOD), which has a plasma half-life of more than 24 h, protects the blood perfused rabbit heart against injury during ischaemia and reperfusion. However, the profile for the dose-dependency of protection was bell-shaped with loss of efficacy below 6000 and above 30,000 U/kg. In the present study, isolated rabbit hearts, perfused with blood from support rabbits, were subjected to a 2 min infusion with St Thomas' Hospital cardioplegic solution followed by 60 min of global ischaemia (37 degrees C) and 60 min of reperfusion. PEG-SOD was administered 1 h or 12-24 h before ischaemia. We assessed the effect of PEG-SOD on ischaemia- and reperfusion-induced changes in: (i) the tissue content of reduced glutathione (GSH), oxidized glutathione (GSSG) and malondialdehyde (MDA) and (ii) the activity of CuZn-SOD, Mn-SOD and glutathione peroxidase and reductase (GPD and GRD). Ischaemia and reperfusion reduced tissue GSH content by 70% and increased GSSG content by 400% (from their fresh aerobic values of 13.1.9 and 0.09 +/- 0.01 nmol/mg protein, respectively). PEG-SOD, given intravenously at various doses to donor and support rabbits 1 h or 12-24 h before ischaemia, protected against these changes with a bell-shaped dose-response relationship. Thus, with 0, 3000, 6000, 12,000, 30,000 and 60,000 U/kg, GSH content was 4.1 +/- 0.4, 4.8 +/- 0.4, 8.5 +/- 0.5, 12.3 +/- 1.6, 12.3 +/- 1.6 and 5.0 +/- 0.5 nmol/mg protein in the 1 h pretreatment group and 4.1 +/- 0.4, 4.2 +/- 0.5, 10.4 +/- 1.5, 11.2 +/- 1.1, 11.4 +/- 0.7 and 4.7 +/- 0.6 nmol/mg protein in the 12-24 h pretreatment group (means +/- S.E.M.). For GSSG the corresponding values were 0.36 +/- 0.04, 0.34 +/- 0.03, 0.12 +/- 0.01, 0.12 +/- 0.01, 0.11 +/- 0.01 and 0.41 +/- 0.03 nmol/mg protein for the 1 h group and 0.36 +/- 0.04, 0.35 +/- 0.02, 0.15 +/- 0.01, 0.12 +/- 0.01, 0.11 +/- 0.01 and 0.34 +/- 0.02 nmol/mg protein for the 12-24 h group. Ischaemia and reperfusion had no effect on tissue MDA content or CuZn-SOD, GDP and GRD activity, and in general, PEG-SOD also lacked significant effect on any of these variables at any dose studied. However, Mn-SOD activity was severely reduced by ischaemia and reperfusion (from 42 +/- 7 U/mg protein in fresh aerobic controls to 6 +/- 1 U/mg protein at the end of reperfusion).(ABSTRACT TRUNCATED AT 400 WORDS)
我们之前已经表明,聚乙二醇共轭超氧化物歧化酶(SOD)的血浆半衰期超过24小时,可保护血液灌注的兔心脏在缺血和再灌注期间免受损伤。然而,保护作用的剂量依赖性曲线呈钟形,在低于6000和高于30,000 U/kg时效力丧失。在本研究中,用来自支持兔的血液灌注的离体兔心脏,先输注2分钟圣托马斯医院心脏停搏液,然后进行60分钟的全心缺血(37℃)和60分钟的再灌注。PEG-SOD在缺血前1小时或12 - 24小时给药。我们评估了PEG-SOD对缺血和再灌注诱导的以下变化的影响:(i)还原型谷胱甘肽(GSH)、氧化型谷胱甘肽(GSSG)和丙二醛(MDA)的组织含量,以及(ii)铜锌超氧化物歧化酶、锰超氧化物歧化酶和谷胱甘肽过氧化物酶及还原酶(GPD和GRD)的活性。缺血和再灌注使组织GSH含量降低70%,GSSG含量增加400%(分别从其新鲜有氧状态下的13.1.9和0.09±0.01 nmol/mg蛋白)。在缺血前1小时或12 - 24小时以不同剂量静脉给予供体和支持兔PEG-SOD,可保护这些变化,剂量反应关系呈钟形。因此,对于1小时预处理组,剂量为0、3000、6000、12,000、30,000和60,000 U/kg时,GSH含量分别为4.1±0.4、4.8±0.4、8.5±0.5、12.3±1.6、12.3±1.6和5.0±0.5 nmol/mg蛋白;对于12 - 24小时预处理组,相应值分别为4.1±0.4、4.2±0.5、10.4±1.5、11.2±1.1、11.4±0.7和4.7±0.6 nmol/mg蛋白(均值±标准误)。对于GSSG,1小时组的相应值分别为0.36±0.04、0.34±0.03、0.12±0.01、0.12±0.01、0.11±0.01和0.41±0.03 nmol/mg蛋白;12 - 24小时组的相应值分别为0.36±0.04、0.35±0.02、0.15±0.01、0.12±0.01、0.11±0.01和0.34±0.02 nmol/mg蛋白。缺血和再灌注对组织MDA含量或铜锌超氧化物歧化酶、GPD和GRD活性无影响,并且一般来说,在任何研究剂量下PEG-SOD对这些变量中的任何一个也无显著影响。然而,缺血和再灌注使锰超氧化物歧化酶活性严重降低(从新鲜有氧对照中的42±7 U/mg蛋白降至再灌注结束时的6±1 U/mg蛋白)。